https://yestino.com/entities/why-lilly-64e756Every event involving Why Lillyenhttps://yestino.com/events/why-lilly-and-novo-are-betting-on-amylin-to-power-a-new-wave-00b369https://yestino.com/events/why-lilly-and-novo-are-betting-on-amylin-to-power-a-new-wave-00b369Fri, 02 Oct 2026 15:13:43 GMTEli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes. Sources: CNBC Business